Navigation Links
Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
Date:9/21/2007

hed to the prevention and treatment for prostate cancer in United States, Russia, and world wide."

The initial two-year partnership has received financial commitments in excess of US$1,000,000. CDRI and DOE will have joint rights to commercialize products in most of the world, whereas CDRI will have exclusive commercial rights for markets in Russia and certain other countries.

About The Global Initiatives for Proliferation Prevention Program of the U.S. Department of Energy (GIPP/DOE): The mission of The Global Initiatives for Proliferation Prevention program encourages and supports cooperative civilian research between US research teams and researchers from the countries of the former USSR, utilizing their extensive hi-tech and scientific experience. The goals of GIPP-sponsored joint projects are to promote identification and utilization of new scientific and technical resources, and to increase the investment appeal and commercial potential of technologies developed in scientific research institutes of the former Soviet Union.

http://www.nnsa.doe.gov

About CDRI: The Chemical Diversity Research Institute, housed in dedicated world-class research facilities in Moscow, is a leading Russian commercial biotech specialized in advanced combinatorial, medicinal and computational chemistry; and high-throughput screening for early drug discovery.

http://www.iihr.ru

About ChemDiv: ChemDiv Inc. (Chemical Diversity) is a global chemistry-driven contract research organization focused on identifying and delivering pre-clinical opportunities and services for life science partners, merging industrial and academic efforts to bring new approaches to the treatment of life-threatening diseases.

http://www.chemdiv.com

About Blokhin Russian Oncology Center (RONC): The Russian Oncology Center
'/>"/>

SOURCE ChemDiv, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chemical in Gila monsters saliva yields Alzheimer drug
2. Biochemical Markers Might Help Predict Heart Problems
3. Chemical found in plants may be the treatment for leukemia
4. Chemicals in clear plastics can cause learning difficulties
5. Harmful chemicals change the genetic response to hormone estrogen
6. Quitting Smoking Made Easy By Track Of New Chemical
7. Brain Chemical Identified For Drug Dependent Behavior
8. Toxic chemicals found in domestic products poisoning newborn babies
9. Block Immune System Chemical For Treating Asthma
10. Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief
11. Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), a ... treat aging diseases. , BioViva announces it has begun a fundraiser through Maximum ... Disease (AD) and find a cure. MaxLife will grant 100% of the money raised ...
(Date:7/31/2015)... ME (PRWEB) , ... July 31, 2015 , ... The alarm was ringing. Hugh Chatfield, ... Glancing out of the window, he recalled that his equipment was set up to depict ... tower, he jumped out of bed. , The photo speaks for itself. Chatfield is also ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... Awarded ... Hair Restoration is proud to announce that they are the latest recipients of the ... cements their status as one of the worldwide leaders in the science of hair ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... selected as a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication ... to help long-term and post-acute care providers understand the benefits of using ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to announce that it ... a mobile application format available on iPhones, iPads, and Android smartphones and tablets. ...
Breaking Medicine News(10 mins):Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3
... 6 May 2010 -- Researchers from Cold Spring Harbor Laboratory ... analyzing the genome of single tumor cells. The breakthrough allows ... tumors develop and has the potential to help doctors identify ... from the prostate or a non-invasive lesion in the breast. ...
... May 2010 -- A new study of metastatic breast ... patients have in their blood directly correlates with the ... Cancer Conference in Brussels, Belgium, the results have the ... these patients. Circulating tumor cells --cancer cells found ...
... After menopause, 6 to 10 million women take hormone ... progestin, to replace hormones lost from inactive ovaries. Progestin ... potentially negative effects of estrogen therapy on the uterus. ... evidence has been found that estrogen and progestin in ...
... ... , ... (PRWEB) May 6, 2010 -- CosmoCom the global leader in Contact Center Consolidation ... prestigious 2010 Long Island Software Award (LISA). Presented by the Long Island Software and ...
... ... steady employment in a highly competitive market. In order to gain a competitive edge against ... appearance. Non-surgical med spa treatments can offer many benefits during a job hunt. , ... (PRWEB) May 6, 2010 -- With ...
... ... achieving top performance from GPUs in diverse applications using Monte Carlo simulations can now ... Group (NAG). , ... (Vocus) May 6, 2010 -- Developers and researchers who are interested in achieving top ...
Cached Medicine News:Health News:Genome breakthrough allows scientists to identify and profile tumor cells from very small samples 2Health News:Survival in metastatic breast cancer directly linked to circulating tumor cells 2Health News:Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds 2Health News:CosmoCom Wins Software Award for CosmoHealth 2Health News:CosmoCom Wins Software Award for CosmoHealth 3Health News:Med Spa Treatments Become More Popular as Unemployment Rates Climb 2Health News:Med Spa Treatments Become More Popular as Unemployment Rates Climb 3Health News:More GPU Routines for Technical Research Now Available from Numerical Algorithms Group 2Health News:More GPU Routines for Technical Research Now Available from Numerical Algorithms Group 3
(Date:7/30/2015)... Japan , July 30, 2015 ... of the study to fulfill the post-marketing commitment ... the Pan European Multi-Database Bladder Cancer Risk ... retrospective matched cohort study, conducted in four European ... HCI) with up to 10 years of follow-up. ...
(Date:7/30/2015)... 30, 2015 Global ENT ... to reach USD 23.01 million in 2022, according to ... base of geriatric population, increasing prevalence of ear, nose, ... of awareness among target customer base are expected serve ... forecast period. According to estimates published by the WHO, ...
(Date:7/30/2015)... LONDON , July 30, 2015 ... devices market ? Which areas are going to grow ... report shows you potential revenues to 2025, assessing data, ... report provides 176 tables, charts, and graphs. ... the future market prospects. Our new study lets you ...
Breaking Medicine Technology:Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... YORK, Oct. 7 Reportlinker.com announces that a ... catalogue: Co-promotion and Co-marketing Agreements ... http://www.reportlinker.com/p0177971/Co-promotion-and-Co-marketing-Agreements-in-Pharma-Biotech-and-Diagnostics-4th-edition.html ... of how and why companies enter co-promotion and ...
... Medica presented " Diagnostic Imaging LIVE ," a virtual ... September 29, 2010.   UBM Studios , a leader ... solutions , provided the 3D platform for the event. ... (Photo: http://photos.prnewswire.com/prnh/20101007/NY78137 ) (Photo: ...
Cached Medicine Technology:Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 2Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 3Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 4Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 5Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 6Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 7Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 8Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 9UBM Medica Presents Diagnostic Imaging LIVE, a Virtual Conference for Radiologists and Imaging Professionals - Now Available On Demand 2UBM Medica Presents Diagnostic Imaging LIVE, a Virtual Conference for Radiologists and Imaging Professionals - Now Available On Demand 3
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid STR, a microbial identification system....
IDS Rapid One, a microbial identification system....
IDS Rapid NF Plus, a microbial identification system....
Medicine Products: